Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Serum and Extracellular Vesicle Micrornas MiR-423, MiR-199 and MiR-93* As Biomarkers for Acute Graft Versus Host Disease

Rachel E Crossland, PhD, Jean Norden, Kim F Pearce, PhD, Mateja Kralj Juric, PhD, Clare Lendrem, Louis A Bibby, Matthew Collin, MD PhD, Hildegard T. Greinix, MD, Anne M Dickinson, PhD

Blood (2016) 128 (22): 4545.

https://doi.org/10.1182/blood.V128.22.4545.4545

Published: 2016

Journal Articles

Expression of Serum Micrornas Are Dysregulated during Acute Graft Versus Host Disease

Rachel E Crossland, PhD, Jean Norden, Mateja Kralj Juric, PhD, Kile Green, PhD, Kim F Pearce, PhD, Clare Lendrem, Hildegard T. Greinix, MD, Anne M Dickinson, PhD

Blood (2016) 128 (22): 5715.

https://doi.org/10.1182/blood.V128.22.5715.5715

Published: 2016

Journal Articles

Urinary Micrornas MiR-377, MiR-423, MiR-93 and MiR-199 As Biomarkers for Graft Versus Host Disease

Rachel E Crossland, PhD, Jean Norden, Matthew Collin, MD PhD, Anne M Dickinson, PhD

Blood (2014) 124 (21): 1088.

https://doi.org/10.1182/blood.V124.21.1088.1088

Published: 2014

Journal Articles

Validation of Isolation Methodology and Endogenous Control Selection for qRT-PCR Assessment of Microrna Expression in Serum and Urine Exosomes

Rachel E Crossland, PhD, Jean Norden, Louis Bibby, BSc, Joanna Davis, BSc, Anne M Dickinson, PhD

Blood (2014) 124 (21): 5793.

https://doi.org/10.1182/blood.V124.21.5793.5793

Published: 2014

Journal Articles

Defining The Optimal Dose Of Alemtuzumab In Unrelated Donor Reduced Intensity Allografts: A UK Retrospective Study

Kile Green, BSc(Hons), Rob Sellar, MD, Laura Jardine, MD, Janice Ward, Paul Ferguson, MD, Pip Nicolson, MD, Kim Pearce, PhD, Venetia Bigley, MD, PhD, Graham Jackson, MD, Sandeep Nagra, MD, Anne M Dickinson, PhD, Kirsty Thomson, MD, Stephen Mackinnon, MD, Charles Craddock, MD, Matthew P. Collin, MD, PhD, Karl S Peggs, MD

Blood (2013) 122 (21): 4540.

https://doi.org/10.1182/blood.V122.21.4540.4540

Published: 2013

Journal Articles

Prospective Validation of a Chronic GvHD-Specific Proteome Pattern (cGvHD-MS14) Post Allogeneic Hematopoietic Stem Cell Transplantation

Eva M. Weissinger, MD, Daniel Wolff, Jochen Metzger, Christiane E Dobbelstein, MD, Stefanie Buchholz, MD, Elke Dammann, Uwe Borchert, Annika Krons, Helmut Diedrich, Michael Stadler, MD, Anne M Dickinson, PhD, Ernst Holler, M.D., Hildegard T. Greinix, MD, Juergen Krauter, MD, Arnold Ganser, MD

Blood (2011) 118 (21): 1970.

https://doi.org/10.1182/blood.V118.21.1970.1970

Published: 2011

Journal Articles

Regulatory T Cells Prevent Effector T Cell Infiltration Into GvHD Target Tissue by Affecting Chemokine Signaling.

Brie Turner, PhD, Shaheda Ahmed, PhD, Sarah Pagan, Jean Norden, Matthew Collin, MD, PhD, Anne M Dickinson, PhD, Xiao Nong Wang, PhD

Blood (2009) 114 (22): 1341.

https://doi.org/10.1182/blood.V114.22.1341.1341

Published: 2009

Journal Articles

Clinical and Genetic Risk Assessment for Overall Survival in Haematopoietic Stem Cell Transplantation (HSCT).

Anne M Dickinson, PhD, Kim F Pearce, CStat, Graham H Jackson, Matthew Collin, MD, PhD, Jean Norden, Ernst Holler, PhD, Heike Bickeboller, Yesilda Balavarca, Vanderson Rocha, Hans-Jochem Kolb, Alvaro Aubano, Ilona Hromadnikova, Petr Sedlacek, Alois Gratwohl

Blood (2009) 114 (22): 1189.

https://doi.org/10.1182/blood.V114.22.1189.1189

Published: 2009

Journal Articles

“ATG16 L1 a Additional Risk Factor for TRM After allogeneic Stem Cell Transplantation”.

Karin Landfried, Martin Hausmann, Gerhard Rogler, Daniel Wolff, Anne M Dickinson, PhD, Matthew Collin, MD, PhD, Juergen Finke, Ernst Holler, PhD, Reinhard Andreesen, MD, PhD

Blood (2009) 114 (22): 1155.

https://doi.org/10.1182/blood.V114.22.1155.1155

Published: 2009

Journal Articles

A Retrospective Study of Alemtuzumab Level, T Cell Chimerism and Graft Versus Host Disease Using Intermediate Dose Alemtuzumab for Matched Related and Matched Unrelated Reduced Intensity Transplantation.

Andrew Charlton, MD, Laura Spence, MD, Venetia Bigley, MD, Natasha Groves, PhD, Geoff Hale, PhD, Sarah Pagan, BSc, Brie E Turner, PhD, Gail Jones, MD, PhD, Graham H Jackson, MD, PhD, Anne M Dickinson, PhD, Matthew Collin, MD, PhD

Blood (2009) 114 (22): 3333.

https://doi.org/10.1182/blood.V114.22.3333.3333

Published: 2009

Journal Articles

Prospective Evaluation of An Agvhd-Specific Proteomic Pattern in More Than 340 Patients.

Eva M. Mischak-Weissinger, MD, Ernst Holler, PhD, Michael Schleuning, Gernot Beutel, Dr., Hildegard Greinix, Anne M Dickinson, PhD, James LM Ferrara, MD, Stefanie Buchholz, MD, Annika Krons, Julia Kontsendorn, Norbert Hahn, Axel R. Zander, Hans-Jochem Kolb, Jochen Metzger, PhD, Arnold Ganser, MD

Blood (2009) 114 (22): 347.

https://doi.org/10.1182/blood.V114.22.347.347

Published: 2009

Journal Articles

Proteomic Screening Applied to the Diagnosis of Chronic Graft-Versus-Host-Disease.

Eva M. Mischak-Weissinger, MD, Michael Stadler, MD, Ernst Holler, PhD, Michael Schleuning, Hildegard Greinix, MD, Hans-Jochem Kolb, MD, Anne M Dickinson, PhD, Annika Krons, Helmut Diedrich, MD, Julia Kontsendorn, Norbert Hahn, Jochen Metzger, PhD, Arnold Ganser, MD

Blood (2009) 114 (22): 1164.

https://doi.org/10.1182/blood.V114.22.1164.1164

Published: 2009

Journal Articles

Mesenchymal Stem Cells and Fibroblasts Have Similar Immunoregulatory Properties In Vitro but Distinct Gene Expression Profiles: Implications for Cellular Therapy.

Muzlifah A. Haniffa, MBBCh, Xiao N. Wang, MD, Udo Holtick, MD, Daniel C. Swan, PhD, Sarah Bullock, BSc, Anne M. Dickinson, PhD, Catharien M. Hilkens, PhD, Matthew P. Collin, MD, PhD

Blood (2007) 110 (11): 1930.

https://doi.org/10.1182/blood.V110.11.1930.1930

Published: 2007

Journal Articles

A Distinct Pattern of Non-HLA Polymorphisms Predicts an Increased Risk for GvHD without Benefit of GvL in HLA Matched Sibling Transplants for Chronic Myeloid Leukemia (CML).

Blood (2006) 108 (11): 54.

https://doi.org/10.1182/blood.V108.11.54.54

Published: 2006

Journal Articles

Investigating the Role of Dendritic Cells in Extracorporeal Photopheresis Using an In Vitro Model.

Udo Holtick, MD, Scott R. Marshall, MD, Muzlifah Haniffa, MD, Catharien M. Hilkens, PhD, Xiao N. Wang, MD,PhD, Anne M. Dickinson, PhD

Blood (2006) 108 (11): 5162.

https://doi.org/10.1182/blood.V108.11.5162.5162

Published: 2006

Journal Articles

The MyD88 Adapter-Like (Mal) Protein Variant Leu 180, a Candidate Polymorphism for Protection Against Graft Versus Host Disease.

Udo Holtick, MD, Peter G. Middleton, PhD, Jane L. Harrold, Ernst Holler, MD, Eliane Gluckman, MD, Ilona Hromadnikova, PhD, Anne M. Dickinson, PhD, Matthew P. Collin, MD,PhD

Blood (2006) 108 (11): 3243.

https://doi.org/10.1182/blood.V108.11.3243.3243

Published: 2006

Journal Articles

CD1a Is a Dimorphic Antigen-Presenting Protein That May Be Mismatched without Increasing the Risk of Graft Versus Host Disease.

Eleanor M. Lanning, Peter G. Middleton, PhD, Anne M. Dickinson, PhD, Ernst Holler, MD, Eliane Gluckman, MD, Ilona Hromadnikova, PhD, Matthew P. Collin, MD

Blood (2005) 106 (11): 1811.

https://doi.org/10.1182/blood.V106.11.1811.1811

Published: 2005

Journal Articles

The Fate of Human Langerhans Cells in Hematopoietic Stem Cell Transplantation.

Matthew P. Collin, MD, Derek N. Hart, MD, Graham H. Jackson, MD, Gordon Cook, MD, James Cavet, MD, Stephen Mackinnon, MD, Anne M. Dickinson, PhD

Blood (2005) 106 (11): 572.

https://doi.org/10.1182/blood.V106.11.572.572

Published: 2005

Journal Articles

Downregulation of Interleukin-13 by PUVA Treatment in a Human Model of Graft-Versus-Host Disease May Highlight the Importance of This Cytokine in the Mechanism of Extracorporeal Phototherapy Treatment.

Scott R. Marshall, MB, ChB, Xiao N. Wang, PhD, Chris M. McArthy, BSc, Graham Jackson, MD, Anne M. Dickinson, PhD

Blood (2005) 106 (11): 5234.

https://doi.org/10.1182/blood.V106.11.5234.5234

Published: 2005

Journal Articles

NOD2/CARD15 Mutations Associate with Transplant Related Mortality and GvHD in HLA-Identical Sibling Transplants: Detailed Analysis of Single SNPs in 211 Recipient/Donor Pairs.

Ernst Holler, MD, PhD, Gerhard Rogler, MD, PhD, Joachim Hahn, MD, Hans Herfarth, MD, PhD, Julia Brenmoehl, Guenther Eissner, PhD, Anne M. Dickinson, PhD, Graham Jackson, MD, Hildegard Greinix, MD, PhD, Gerhard Fischer, MD, PhD, Daniel Wolff, MD, Beate Steiner, MD, Joerg Marienhagen, MD, PhD, Reinhard Andreesen, MD.PhD

Blood (2004) 104 (11): 424.

https://doi.org/10.1182/blood.V104.11.424.424

Published: 2004

NARROW

Serum and Extracellular Vesicle Micrornas MiR-423, MiR-199 and MiR-93* As Biomarkers for Acute Graft Versus Host Disease

Expression of Serum Micrornas Are Dysregulated during Acute Graft Versus Host Disease

Urinary Micrornas MiR-377, MiR-423, MiR-93 and MiR-199 As Biomarkers for Graft Versus Host Disease

Validation of Isolation Methodology and Endogenous Control Selection for qRT-PCR Assessment of Microrna Expression in Serum and Urine Exosomes

Defining The Optimal Dose Of Alemtuzumab In Unrelated Donor Reduced Intensity Allografts: A UK Retrospective Study

Prospective Validation of a Chronic GvHD-Specific Proteome Pattern (cGvHD-MS14) Post Allogeneic Hematopoietic Stem Cell Transplantation

Regulatory T Cells Prevent Effector T Cell Infiltration Into GvHD Target Tissue by Affecting Chemokine Signaling.

Clinical and Genetic Risk Assessment for Overall Survival in Haematopoietic Stem Cell Transplantation (HSCT).

“ATG16 L1 a Additional Risk Factor for TRM After allogeneic Stem Cell Transplantation”.

A Retrospective Study of Alemtuzumab Level, T Cell Chimerism and Graft Versus Host Disease Using Intermediate Dose Alemtuzumab for Matched Related and Matched Unrelated Reduced Intensity Transplantation.

Prospective Evaluation of An Agvhd-Specific Proteomic Pattern in More Than 340 Patients.

Proteomic Screening Applied to the Diagnosis of Chronic Graft-Versus-Host-Disease.

Mesenchymal Stem Cells and Fibroblasts Have Similar Immunoregulatory Properties In Vitro but Distinct Gene Expression Profiles: Implications for Cellular Therapy.

A Distinct Pattern of Non-HLA Polymorphisms Predicts an Increased Risk for GvHD without Benefit of GvL in HLA Matched Sibling Transplants for Chronic Myeloid Leukemia (CML).

Investigating the Role of Dendritic Cells in Extracorporeal Photopheresis Using an In Vitro Model.

The MyD88 Adapter-Like (Mal) Protein Variant Leu 180, a Candidate Polymorphism for Protection Against Graft Versus Host Disease.

CD1a Is a Dimorphic Antigen-Presenting Protein That May Be Mismatched without Increasing the Risk of Graft Versus Host Disease.

The Fate of Human Langerhans Cells in Hematopoietic Stem Cell Transplantation.

Downregulation of Interleukin-13 by PUVA Treatment in a Human Model of Graft-Versus-Host Disease May Highlight the Importance of This Cytokine in the Mechanism of Extracorporeal Phototherapy Treatment.

NOD2/CARD15 Mutations Associate with Transplant Related Mortality and GvHD in HLA-Identical Sibling Transplants: Detailed Analysis of Single SNPs in 211 Recipient/Donor Pairs.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only